在儿童腹中使用益生菌,益生菌和共生菌
E M S Martins1, L C Nascimento da Silva1, M S Carmo1,2
1Laboratório de Patogenicidade Microbiana, Universidade Ceuma, São Luís, MA, Brasil.
概括
儿童急性腹是全球主要的健康问题. 益生菌,益生菌和协生菌在恢复肠道健康和减少疾病持续时间方面表现有前途,尽管需要进一步的研究.
科学领域:
- 儿科 儿科 儿科
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 全球范围内,急性腹是5岁以下儿童死亡的主要原因.
- 标准的电解替代剂不能恢复肠道微生物群.
- 益生菌,益生菌和协生菌正在探索恢复肠道平衡.
研究的目的:
- 审查儿童腹,重点关注恢复肠道微生物群的治疗方法.
- 突出益生菌,益生菌和共生菌的有效性和潜在副作用.
- 强调需要进一步研究有效的预防和治疗方案.
主要方法:
- 对儿童腹现有文献的描述性综述.
- 对治疗腹的益生菌,益生菌和共生菌的研究分析.
- 检查肠道微生物群恢复和恒温的研究.
主要成果:
- 益生菌,益生菌和共生菌治疗有效地减少了腹的持续时间,副作用最小.
- 这些疗法有助于重组肠道平衡.
- 一些患者的争议和不良反应需要进一步调查.
结论:
- 益生菌,益生菌和协生菌为治疗儿童腹提供了一个有希望的替代方案.
- 需要进行进一步的研究,以解决菌株多样性和病原体特异性,以优化治疗方案.
- 开发有效的预防和治疗策略仍然是优先事项.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
118
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
118
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
206
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
206
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Diarrhea-Predominant IBS
161
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
161
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
193
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
193
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127


